Tilray Brands Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Brands Inc
MHI Pioneer Municipal High Income Fund, Inc.
GLW Corning Inc
PAYS Paysign Inc
ALTR Altair Engineering Inc
CVX Chevron Corp
ASCB ASPAC II Acquisition Corp
STRS Stratus Properties Inc
ESMC Escalon Medical Corp
ATO Atmos Energy Corp
Go

Health Care : Pharmaceuticals | Mid Cap Value
Based in Canada
Company profile

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: cannabis business, distribution business, beverage alcohol business, and wellness business. The cannabis business segment is engaged in the cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The distribution business segment is engaged in the purchase and resale of pharmaceutical and wellness products. The beverage alcohol business segment is engaged in the production, marketing, and sale of beverage alcohol products. The wellness business segment is engaged in the production, marketing and distribution of hemp-based food and other wellness products. It offers a broad-based portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. It is also a hemp food manufacturer. It has operations in Canada, the United States, Europe, Australia, and Latin America.

Closing Price
$2.75
Day's Change
-0.11 (-3.85%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.92
Day's Low
2.75
Volume
(Light)
Volume:
11,862,163

10-day average volume:
15,929,589
11,862,163

HEXO Corp.'s Shareholders Approve Note Transaction with Tilray Brands

7:00 am ET July 5, 2022 (Globe Newswire) Print

EQNX::TICKER_START (TSX:HEXO),(NASDAQ:HEXO),(TSX:TLRY), EQNX::TICKER_END This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021.

HEXO Corp ("HEXO" or the "Company") (TSX: HEXO; NASDAQ: HEXO) is pleased to announce that at its reconvened special meeting of shareholders held today (the "Meeting"), holders ("Shareholders") of common shares of HEXO ("Common Shares") approved the previously announced transaction (the "Note Transaction") with Tilray Brands, Inc. ("Tilray Brands") (Nasdaq | TSX: TLRY) and HT Investments MA LLC ("HTI"). The Meeting was originally held on June 14, 2022 and was adjourned prior to Shareholders voting on the Note Transaction in order to provide Shareholders with additional time to consider the previously announced amendments to the Note Transaction.

At the Meeting, Shareholders voted in favour of the ordinary resolution (the "Note Amendment Resolution") to approve certain aspects of the Note Transaction, which provides for the amendment to the terms of the outstanding senior secured convertible note (the "Note") originally issued by HEXO to HTI and the execution of an amended and restated Note (the "Amended Note") with HTI that will be immediately thereafter assigned to Tilray Brands pursuant to the terms of an assignment and assumption agreement. The Note Amendment Resolution was approved by 87.246% of the votes cast by Shareholders at the Meeting. A total of 80,423,499 Common Shares (approximately 17.55% of the issued and outstanding Common Shares) were represented at the Meeting.

Shareholder approval is a condition to closing the Note Transaction. The Company previously obtained, on May 13, 2022, conditional approval from the Toronto Stock Exchange for the Note Transaction and clearance from the Competition Bureau on July 4, 2022. Closing of the Note Transaction remains subject to the fulfilment of certain other conditions and is expected to occur in the third quarter of 2022.

Forward-Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws ("Forward-Looking Statements"), including with respect to: the timing to receive required regulatory approvals in connection with the Note Transaction; the conditions of the Note Transaction described herein; and the anticipated timing of the closing of the Note Transaction. Forward-Looking Statements are based on certain expectations and assumptions and are subject to known and unknown risks and uncertainties and other factors that could cause actual events, results, performance and achievements to differ materially from those anticipated in these Forward-Looking Statements. Forward-Looking Statements should not be read as guarantees of future performance or results. Readers are cautioned not to place undue reliance on these Forward-Looking Statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any Forward-Looking Statements as a result of new information or future events, or for any other reason.

This press release should be read in conjunction with the management's discussion and analysis and unaudited condensed consolidated interim financial statements and notes thereto as at and for the three months and nine months ended April 30, 2022. Additional information about HEXO is available on the Company's profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov, including the Company's Annual Information Form for the year ended July 31, 2021 dated October 29, 2021.

Neither the TSX nor NASDAQ accepts responsibility for the adequacy or accuracy of this release.

About HEXO

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market in Canada and Israel. The Company also serves the Colorado market through its Powered by HEXO(R) strategy and Truss CBD USA, a joint venture with Molson-Coors. With the completion of HEXO's acquisitions of Redecan and 48North, HEXO is a leading cannabis products company in Canada by recreational market share. For more information, please visit hexocorp.com.

For further information, please contact:

Investor Relations:

invest@hexo.com

www.hexocorp.com

For media inquiries please contact:

Christy Theriault, Kaiser & Partners Communications

christy.theriault@kaiserpartners.com

416.993.9047

https://ml.globenewswire.com/media/ee1f36d0-a81b-4d8c-b4f2-60d2d6d58a8c/small/hexo-corp-ir-ticker-blue-png.png

https://ml.globenewswire.com/media/ee1f36d0-a81b-4d8c-b4f2-60d2d6d58a8c/small/hexo-corp-ir-ticker-blue-png.png

comtex tracking

COMTEX_409706680/2010/2022-07-05T07:00:42

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.